arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

COLLEGIUM PHARMACEUTICAL, INC

COLL
$25.19 ▲ +1.52 (+6.42%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
52 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
80
Health
Good
Bullish
auto_awesome

Analytical Summary

COLLEGIUM PHARMACEUTICAL, INC shows strong fundamentals with top-quartile Return on Common Equity (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $817.7M
Dividend Yield —
Revenue Growth 6.3% ↘
Op. Margin 1.9% ↘
ROIC 1.3% ↘
FCF / Share $2.18 ↗
Trailing P/E —
Price / Book 2.6x
FCF Yield 8.7%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

52-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$199.88M
↑ +6.3% —
Net Income Profit after all expenses
$14.50M
↑ +499.8% —
Operating Margin Operating profit as % of sales
1.9%
↓ -88.4% 79th
FCF / Share Free cash flow per share
$2.18
↑ +23.2% —
Long-Term Debt Long-term obligations
$11.50M
— 0.0% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
78
Returns ↓
87
Financial Health ↑
63
Cash Quality ↑
95

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 14 years · 52 quarters